LivaNova PLC Stock 12‑Month Price Target Raised to $103.5, Implies 30% Upside

What happened

Analysts’ average 12-month price target for LivaNova PLC rose from $92.1 to $103.5, based on estimates from 10 analysts. Using the Nov. 3 closing price, the new target implies approximately 30% potential upside; the consensus rating remains Buy among 12 analysts.

Confirmed

Global impact / market context

A higher analyst target signals improved expectations for LivaNova’s share value, but it does not guarantee a gain. If investors act on the forecasts, buying could support the share price; weaker company results or changed assumptions could instead reduce confidence and pressure it.

Analyst inference

The target increase comes from a subset of 10 analysts, while the broader 12-analyst consensus remains Buy, with nine Buys, three Holds and no Sells. Forecasts range from $75 to $120, showing meaningful disagreement about potential value.

Confirmed

What to watch

1. Check whether future analyst target updates continue to move higher or reverse, and whether the number of analysts contributing estimates changes from the current 10. Analyst inference
2. Compare LivaNova’s reported business results with the expectations behind the $103.5 target; weaker performance could challenge the implied upside and prompt analysts to lower forecasts. Analyst inference
3. Watch for changes in the 12-analyst rating mix: any shift from Buy toward Hold or Sell would indicate less favorable analyst views than the current consensus. Analyst inference

Evidence

• Original source link unavailable